Cargando…

SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines

BACKGROUND: Development of a universal cancer vaccine for the prevention of all cancers has been under development for many years. Antiangiogenic cancer vaccines elicit immune responses with the potential of destroying tumor vasculature endothelial cells without affecting vasculature integrity in no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lokhov, Petr G., Balashova, Elena E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396256/ https://www.ncbi.nlm.nih.gov/pubmed/27903220 http://dx.doi.org/10.2174/1872208309666161130140535

Ejemplares similares

Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
por: Lokhov, Petr G, et al.
Publicado: (2015)

SANTAVAC(TM): Summary of Research and Development
por: Lokhov, Petr G., et al.
Publicado: (2019)

Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2016)

Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
por: Lokhov, Petr G., et al.
Publicado: (2022)

Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010)

Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021)

Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence
por: Balashova, Elena E., et al.
Publicado: (2012)

Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro
por: Lokhov, Petr G., et al.
Publicado: (2013)

n-Butylamine for Improving the Efficiency of Untargeted Mass Spectrometry Analysis of Plasma Metabolite Composition
por: Maslov, Dmitry L., et al.
Publicado: (2019)

Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2023)

A Metabolomics Approach to Pharmacotherapy Personalization
por: Balashova, Elena E., et al.
Publicado: (2018)

Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
por: Lokhov, Petr G., et al.
Publicado: (2020)

Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
por: Lokhov, Petr G., et al.
Publicado: (2020)

Metabolomic Laboratory-Developed Tests: Current Status and Perspectives
por: Lichtenberg, Steven, et al.
Publicado: (2021)

Evaluation of Dried Blood Spot Sampling for Clinical Metabolomics: Effects of Different Papers and Sample Storage Stability
por: Trifonova, Oxana P., et al.
Publicado: (2019)

In Situ Mass Spectrometry Diagnostics of Impaired Glucose Tolerance Using Label-Free Metabolomic Signature
por: Lokhov, Petr G., et al.
Publicado: (2020)

Current State and Future Perspectives on Personalized Metabolomics
por: Trifonova, Oxana P., et al.
Publicado: (2023)

Personal Metabolomics: A Global Challenge
por: Lokhov, Petr G., et al.
Publicado: (2021)

Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022)

Label-free data standardization for clinical metabolomics
por: Lokhov, Petr G., et al.
Publicado: (2017)

Metabolome Profiling in Aging Studies
por: Balashova, Elena E., et al.
Publicado: (2022)

Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2020)

Mass Spectrometric Blood Metabogram: Acquisition, Characterization, and Prospects for Application
por: Lokhov, Petr G., et al.
Publicado: (2023)

Comparative Metabolomic Study of Drosophila Species with Different Lifespans
por: Maslov, Dmitry L., et al.
Publicado: (2021)

Diagnosing Impaired Glucose Tolerance Using Direct Infusion Mass Spectrometry of Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2014)

Targeting Antigens for Universal Influenza Vaccine Development
por: Nguyen, Quyen-Thi, et al.
Publicado: (2021)

Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
por: Trifonova, Oxana P., et al.
Publicado: (2020)

Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
por: Maslov, Dmitry L., et al.
Publicado: (2022)

Clinical Blood Metabogram: Application to Overweight and Obese Patients
por: Lokhov, Petr G., et al.
Publicado: (2023)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010)

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
por: Wang, Siling, et al.
Publicado: (2022)

Novel Platforms for the Development of a Universal Influenza Vaccine
por: Kumar, Arun, et al.
Publicado: (2018)

Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond
por: Urbanska, Katarzyna, et al.
Publicado: (2012)

Metabolomics Community in Russia: History of Development, Key Participants, and Results
por: Balashova, Elena E., et al.
Publicado: (2020)

Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine
por: Stylianou, Elena, et al.
Publicado: (2018)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Linking Clinical Blood Metabogram and Gut Microbiota
por: Lokhov, Petr G., et al.
Publicado: (2023)

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development
por: Aguiar, Joao C., et al.
Publicado: (2015)

Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development
por: Leitão, Jorge H., et al.
Publicado: (2020)

Challenges to the development of antigen-specific breast cancer vaccines
por: Scanlan, Matthew J, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_onbjgtu6scadnb5etg69eig2lt